An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs

Published:2023-02 Issue: Volume:554 Page:216024
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Gandullo-Sánchez Lucía^ORCID,Pandiella Atanasio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference63 articles.

1. The HER‐2 receptor and breast cancer: ten years of targeted anti–HER‐2 therapy and personalized medicine;Ross;Oncol.,2009

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Prevalence and role of HER2 mutations in cancer;Cocco;Pharmacol. Ther.,2019

4. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells;Di Fiore;Science,1987

5. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat. Rev. Clin. Oncol.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis;Cancer Letters;2024-10

2. SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway;Cancer Letters;2024-10

3. Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer;Oncogenesis;2024-08-04

4. Patient derived cancer organoids model the response to HER2-CD3 bispecific antibody (BsAbHER2) generated from hydroxyapatite gene delivery system;Cancer Letters;2024-08

5. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3